다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Surface Oncology Inc (SURF)
Surface Oncology Inc (SURF) 뉴스

SURF

Surface Oncology (SURF)

Surface Oncology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SURF

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/09/13	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SURF	Surface Oncology Inc
2023/09/13	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:10	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:09	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:08	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:07	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:06	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:05	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:04	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:03	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/09/09	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/09/08	22:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SURF	Surface Oncology Inc
2023/09/01	06:18	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SURF	Surface Oncology Inc
2023/09/01	05:01	GlobeNewswire Inc.	Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences	NASDAQ:SURF	Surface Oncology Inc
2023/08/31	05:34	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SURF	Surface Oncology Inc
2023/08/31	05:32	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:SURF	Surface Oncology Inc
2023/08/31	05:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SURF	Surface Oncology Inc
2023/08/12	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/08/12	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/08/12	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SURF	Surface Oncology Inc
2023/08/02	20:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SURF	Surface Oncology Inc
2023/08/02	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SURF	Surface Oncology Inc
2023/08/02	20:00	GlobeNewswire Inc.	Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023	NASDAQ:SURF	Surface Oncology Inc
2023/07/27	05:56	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:SURF	Surface Oncology Inc
2023/07/20	21:00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:SURF	Surface Oncology Inc
2023/07/13	06:08	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:SURF	Surface Oncology Inc

검색 관련기사 보기:NASDAQ:SURF

1 2 3 4 5 6 7 8 9 10 다음 >>

Invesco QQQ Trust Series 1

Health Care Select Sector

US Dollar vs Yen

Gold vs US Dollar

Energy Select Sector SPDR

Verizon Communications

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관